ALPH — AlphaHelix Molecular Diagnostics AB (publ) Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro CapNeutral
- SEK39.31m
- SEK33.12m
- SEK34.68m
Annual balance sheet for AlphaHelix Molecular Diagnostics AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
R2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | Interim Report | ARS | ARS | PRESS |
| Standards: | SAS | — | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.29 | 0.412 | 1.42 | 5.86 | 7.84 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.71 | 3.26 | 3.2 | 8.8 | 5.73 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 9.2 | 8.29 | 9.81 | 21.7 | 20.1 |
| Net Property, Plant And Equipment | 0.761 | 0.504 | 0.093 | 0.075 | 0.118 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 10 | 8.79 | 9.9 | 32.1 | 28.8 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7.41 | 7.31 | 6 | 8.15 | 7.69 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 7.54 | 7.31 | 6.9 | 9.95 | 8.91 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 2.47 | 1.49 | 3 | 22.1 | 19.9 |
| Total Liabilities & Shareholders' Equity | 10 | 8.79 | 9.9 | 32.1 | 28.8 |
| Total Common Shares Outstanding |